Welcome!

Premium Advice
- My Services
- None
- Other Services
- Champion Funds
- Duke Street
- Global Gains
- Hidden Gems
- Income Investor
- Inside Value
- Million Dollar Portfolio
- Motley Fool Options
- Motley Fool Pro
- Pay Dirt
- Ready-Made Millionaire
- Rule Breakers
- Rule Your Retirement
- Stock Advisor
- *Get a Fool Credit Card

Help Join Now or

The Motley Fool

Updated: 12/4/2009 10:53 AM					Sponsored by:
	DOW	10483.59	117.44	1.13%
	S&P 500	1111.57	11.65	1.06%
	NASD	2202.98	29.84	1.37%

$11.86 0.20 (+1.72%)

12/4/2009 11:50 AM

InterMune, Inc. (ITMN)

CAPS Rating: 2 out of 5

2 out of 5

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology.

Sponsored Links

Featured Broker Partners